Computational analysis of interactions of argadin with chitotriosidase, chitinase and acidic mammalian chitinase: Hints for specific inhibitor design

Letters in Drug Design and Discovery

Volumn 7, Issue 5, 2010, Pages 324-331

  Aparoy, P ^a   Reddy, R N ^b   Guruprasad, Lalitha ^a   Reddanna, P ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b Rational Labs (P) Limited   (India)

Author keywords

Acidic mammalian chitinase; Argadin; Asthma; Chitotriosidase; Molecular mechanics calculations

Indexed keywords

ARGADIN; CHITINASE; CHITINASE INHIBITOR; CHITOTRIOSIDASE; ENZYME INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ASPERGILLUS FUMIGATUS; COMPLEX FORMATION; COMPUTER ANALYSIS; DRUG SPECIFICITY; ENZYME INHIBITOR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 77953693079     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010791163514     Document Type: Article

References (49)

1. McKenzie, A. N. Regulation of t helper type 2 cell immunity by interleukin-4 and interleukin-13. Pharmacol. Ther. 2000, 88, 143-151.
2. Shuhui, L.; Mok, Y. K.; Wong, W. S. Role of mammalian chitinases in asthma. Int. Arch. Allergy Immunol., 2009, 149, 369-377.
3. Elias, J. A.; Homer, R. J.; Hamid, Q.; Lee, C. G. Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. J. Allergy Clin. Immunol., 2005, 116, 497-500.
4. Zhu, Z.; Zheng, T.; Homer, R. J.; Kim, Y. K.; Chen, N. Y.; Cohn, L.; Hamid, Q.; Elias, J. A. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science, 2004, 304, 1678-1682.
5. Boot, R. G.; Blommaart, E. F.; Swart, E.; Ghauharali-van der Vlugt, K.; Bijl, N.; Moe, C.; Place, A.; Aerts, J. M. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J. Biol. Chem., 2001, 276, 6770-6778.
6. Debono, M.; Gordee, R.S. Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol., 1994, 48, 471-497.
7. Neville, A.C.; Parry, D.A.; Woodhead-Galloway, J. The chitin crystallite in arthropod cuticle. J. Cell Sci., 1976, 21, 73-82.
8. Araujo, A.C.; Souto-Padron, T.; de Souza, W. Cytochemical localization of carbohydrate residues in microfilariae of Wuchereria bancrofti and Brugia malayi. J. Histochem. Cytochem., 1993, 41, 571-578.
9. Nio, J.; Fujimoto, W.; Konno, A.; Kon, Y.; Owhashi, M.; Iwanaga, T. Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohisto-chemistry. Histochem. Cell Biol., 2004, 121, 473-482.
10. Johansen, J.S.; Hvolris, J.; Hansen, M.; Backer, V.; Lorenzen, I.; Price, P.A. Serum ykl-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of ykl-40 in patients with osteoarthritis or trauma of the knee joint. Br. J. Rheumatol., 1996, 35, 553-559.
11. Renkema, G.H.; Boot, R.G.; Muijsers, A.O.; Donker-Koopman, W.E.; Aerts, J.M. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J. Biol. Chem., 1995, 270, 2198-2202.
12. Boot, R.G.; van Achterberg, T.A.; van Aken, B.E.; Renkema, G.H.; Jacobs, M.J.; Aerts, J.M.; de Vries, C.J. Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macro-phages. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 687-694.
13. Hollak, C.E.; van Weely, S.; van Oers, M.H.; Aerts, J.M. Marked elevation of plasma chitotriosidase activity. A novel hallmark of gaucher disease. J. Clin. Invest., 1994, 93, 1288-1292.
14. Seibold, M.A.; Donnelly, S.; Solon, M.; Innes, A.; Woodruff, P.G.; Boot, R.G.; Burchard, E.G.; Fahy, J.V. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J. Allergy Clin. Immunol., 2008, 122, 944-950.
15. Iyer, A.; van Eijk, M.; Silva, E.; Hatta, M.; Faber, W.; Aerts, J.M.; Das, P.K. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy. Clin. Immunol., 2009, 131, 501-509.
16. van Eijk, M.; van Roomen, C.P.; Renkema, G.H.; Bussink, A.P.; Andrews, L.; Blommaart, E.F.; Sugar, A.; Verhoeven, A.J.; Boot, R.G.; Aerts, J.M. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int. Immunol., 2005, 17, 1505-1512.
17. Donnelly, L.E.; Barnes, P.J. Acidic mammalian chitinase--a potential target for asthma therapy. Trends Pharmacol. Sci., 2004, 25, 509-511.
18. Ramanathan, M., Jr.; Lee, W.K.; Lane, A.P. Increased expression of acidic mammalian chitinase in chronic rhinosinusitis with nasal polyps. Am. J. Rhinol., 2006, 20, 330-335.
19. Seibold, M.A.; Reese, T.A.; Choudhry, S.; Salam, M.T.; Beckman, K.; Eng, C.; Atakilit, A.; Meade, K.; Lenoir, M.; Watson, H.G.; Thyne, S.; Kumar, R.; Weiss, K.B.; Grammer, L.C.; Avila, P.; Schleimer, R.P.; Fahy, J.V.; Rodriguez-Santana, J.; Rodriguez-Cintron, W.; Boot, R.G.; Sheppard, D.; Gilliland, F.D.; Locksley, R.M.; Burchard, E.G. Differential enzymatic activity of common haplotypic versions of the human acidic Mammalian Chitinase protein. J. Biol. Chem., 2009, 284, 19650-19658.
20. Yang, C.J.; Liu, Y.K.; Liu, C.L.; Shen, C.N.; Kuo, M.L.; Su, C.C.; Tseng, C.P.; Yen, T.C.; Shen, C.R. Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma. Hum. Gene Ther., 2009, 20, 1597-1606.
21. Bussink, A.P.; Vreede, J.; Aerts, J.M.; Boot, R.G. A single histidine residue modulates enzymatic activity in acidic mammalian chitinase. FEBS Lett., 2008 582, 931-935.
22. Rao, F.V.; Houston, D.R.; Boot, R.G.; Aerts, J.M.; Hodkinson, M.; Adams, D.J.; Shiomi, K.; Omura, S.; van Aalten, D.M. Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases. Chem. Biol., 2005, 12, 65-76.
23. Olland, A.M.; Strand, J.; Presman, E.; Czerwinski, R.; Joseph-McCarthy, D.; Krykbaev, R.; Schlingmann, G.; Chopra, R.; Lin, L.; Fleming, M.; Kriz, R.; Stahl, M.; Somers, W.; Fitz, L.; Mosyak, L. Triad of polar residues implicated in pH specificity of acidic mammalian chitinase. Protein Sci., 2009, 18, 569-578.
24. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The protein data bank. Nucleic Acids Res., 2000, 28, 235-242.
25. Galaxy Molecular Modeling Software and AM2000 Macromolecular Simulation Package. AM Technologies, Inc. San Antonio, Texas, USA, 1995.
26. Cornell, W.D.; Piotr, C.; Christopher, I.B.; Gould, I.R.; Merz, K.M.; Ferguson, D.M.; Spellmeyer, D.C.; Thomas, F.; Caldwell, J.W.; Kollman, P.A. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc., 1995, 117, 5179-5197.
27. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M. A., Cheeseman, J.R.; Montgomery, J. A. Jr; Vreven, T.; Kudin, K.N.; Burant, J.C.; Millam, J.M.; Iyengar, S.S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G.A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J.E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G.A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V.G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C.Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M W.; Gonzalez, C.; Pople, J. A. Gaussian 03, Revision C.02. Gaussian Inc, Wallingford, CT, 2006
28. Chirlian, L.E.; Francl, M.M. Atomic charges derived from electrostatic potentials: A detailed study. J. Comput. Chem., 1987, 8, 894-905.
29. Reddy, R.N.; Mutyala, R.; Aparoy, P.; Reddanna, P.; Reddy, M.R. Computer aided drug design approaches to develop cyclooxy-genase based novel anti-inflammatory and anti-cancer drugs. Curr. Pharm. Des., 2007, 13, 3505-3517.
30. Jones, G.; Willett, P.; Glen, R.C.; Leach, A.R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol., 1997, 267, 727-748.
31. Sansom, C.E.; Wu, J.; Weber, I.T. Molecular mechanics analysis of inhibitor binding to HIV-1 protease. Protein Eng., 1992, 5, 659-667.
32. Montgomery, J.A.; Niwas, S.; Rose, J.D.; Secrist, J.A.; 3rd, Babu, Y.S.; Bugg, C.E.; Erion, M.D.; Guida, W.C.; Ealick, S.E. Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine. J. Med. Chem., 1993, 36, 55-69.
33. Erion, M.D.; Stoeckler, J.D.; Guida, W.C.; Walter, R.L.; Ealick, S.E. Purine nucleoside phosphorylase. 2. Catalytic mechanism. Biochemistry, 1997, 36, 11735-11748.
34. [34] Reddy, M.R.; Viswanadhan, V. N.; Erion, M.D. In: Kubinyi, H.; Folkers, G.; Martin, Y.C.; Eds. 3D QSAR in drug design,. Kluwer Academic Publishers, New York, NY, 1998, vol. 2, p. 85.
35. Aparoy, P.; Reddy, R.N.; Guruprasad, L.; Reddy, M.R.; Reddanna, P. Homology modeling of 5-lipoxygenase and hints for better inhibitor design. J. Comput. Aided Mol. Des., 2008, 22, 611-619.
36. Reddy, M.R.; Erion, M.D. Computer-aided drug design strategies used in the discovery of fructose 1, 6-bisphosphatase inhibitors. Curr. Pharm. Des., 2005, 11, 283-294.
37. Reddy, M.R.; Erion, M.D. Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach. J. Am. Chem. Soc., 2001, 123, 6246-6252.
38. Ludi score user guide, Accelrys, Inc., San Diego, USA, 1999.
39. van Aalten, D.M.; Komander, D.; Synstad, B.; Gaseidnes, S.; Peter, M.G.; Eijsink, V.G. Structural insights into the catalytic mechanism of a family 18 exo-chitinase. Proc. Natl. Acad. Sci. USA, 2001, 98, 8979-8984.
40. Papanikolau, Y.; Prag, G.; Tavlas, G.; Vorgias, C.E.; Oppenheim, A.B.; Petratos, K. High resolution structural analyses of mutant chitinase A complexes with substrates provide new insight into the mechanism of catalysis. Biochemistry, 2001, 40, 11338-11343.
41. Houston, D.R.; Shiomi, K.; Arai, N.; Omura, S.; Peter, M.G.; Turberg, A.; Synstad, B.; Eijsink, V.G.; van Aalten, D.M. High-resolution structures of a chitinase complexed with natural product cyclopentapeptide inhibitors: Mimicry of carbohydrate substrate. Proc. Natl. Acad. Sci. USA, 2002, 99, 9127-9132.
42. Terwisscha van Scheltinga, A.C.; Kalk, K.H.; Beintema, J.J.; Dijkstra, B.W. Crystal structures of hevamine, a plant defence protein with chitinase and lysozyme activity, and its complex with an inhibitor. Structure, 1994, 2, 1181-1189.
43. Tjoelker, L.W.; Gosting, L.; Frey, S.; Hunter, C.L.; Trong, H.L.; Steiner, B.; Brammer, H.; Gray, P.W. Structural and functional definition of the human chitinase chitin-binding domain. J. Biol. Chem., 2000, 275, 514-520.
44. Perrakis, A.; Tews, I.; Dauter, Z.; Oppenheim, A.B.; Chet, I.; Wilson, K.S.; Vorgias, C.E. Crystal structure of a bacterial chitinase at 2.3 Å resolution. Structure, 1994, 2, 1169-1180.
45. Gouda, H.; Terashima, S.; Iguchi, K.; Sugawara, A.; Saito, Y.; Yamamoto, T.; Hirose, T.; Shiomi, K.; Sunazuka, T.; Omura, S.; Hirono, S. Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin. Bioorg. Med. Chem., 2009, 17, 6270-6278.
46. Zhao, Y.S.; Zheng, Q.C.; Zhang, H.X.; Chu, H.Y.; Sun, C.C. Analysis of a three-dimensional structure of human acidic mammalian chitinase obtained by homology modeling and ligand binding studies. J. Mol. Model, 2009, 15, 499-505.
47. Gouda, H.; Sunazuka, T.; Iguchi, K.; Sugawara, A.; Hirose, T.; Noguchi, Y.; Saito, Y.; Yanai, Y.; Yamamoto, T.; Watanabe, T.; Shiomi, K.; Omura, S.; Hirono, S. Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens. Bioorg. Med. Chem. Lett., 2009, 19, 2630-2633.
48. Ober, C.; Chupp, G.L. The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr. Opin. Allergy Clin. Immunol., 2009, 9, 401-408.
49. Guan, S.P.; Mok, Y.K.; Koo, K.N.; Chu, K.L.; Wong, W.S. Chitinases: biomarkers for human diseases. Protein Pept. Lett., 2009, 16, 490-498.